Accuray launches new TomoHDA and gets FDA okay for CyberKnife M6

New TomoTherapy System enables faster planning and more focused delivery often resulting in half beam-on time than previously.CyberKnife M6 (shown above) is a 3D image-guided and robotically controlled beam and patient positioning radiology delivery system.Accuray stock (ARAY:NASDAQ) is up 64% year-to-date from $2.72 to $6.95.